Abbott Profit Boosted by Key Drug Sales

Stock quotes in this article: ABT , JNJ  

Worldwide nutritional sales rose 4%, while diagnostics sales fell 6% in the second quarter.

Abbott forecast third-quarter adjusted earnings in the range of 88 cents to 90 cents a share. The current consensus estimate is 90 cents a share.

Abbott shares closed Tuesday at $46.49. The stock is down 13% year to date.

  • Loading Comments...
  •  
1 2
Next >

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin
Adam Feuerstein writes regularly for TheStreet.com. In keeping with TSC's editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet.com. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,452.68 1,109.24 2,185.03 33.23
Oil *
77.73
DOWN
18.90
UP
0.38
UP
9.22
UP
0.48
10 Yr
3.32%
SPDR Gold
119.18
-0.18%
+0.03%
+0.42%
+1.47%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services